Press Releases

;

71 patient groups comment on how nondiscrimination in healthcare rule can improve prescription drug access

Oct 3, 2022

The HIV+Hepatitis Policy Institute (HIV+Hep) and the Autoimmune Association, along with 69 other patient organizations, commented on how the Section 1557 nondiscrimination in healthcare proposed rule can be used to improve patient access to prescription drugs. In their comment letter, the patient groups expressed strong support for the “meaningful steps to improve upon current regulations to ensure that people are not discriminated against in healthcare. In several instances, you have proposed to restore protections that had been included in the past but later withdrawn. In other instances, you have provided further clarity on what constitutes discrimination. In any instance, we emphasize that the law and whatever is finalized in regulation must be strictly enforced.”

read more

Texas court decision on PrEP must not stand: Preventing HIV is a public health imperative

Sep 7, 2022

Preventive services covered by private insurance plans without cost- sharing, such as HIV testing, hepatitis B and C testing, and PrEP, are all critical and well-established public health preventive services that must continue. To single out PrEP, which are FDA approved drugs that effectively prevent HIV, and conclude that its coverage violates the religious freedom of certain individuals, is plain wrong, highly discriminatory, and impedes the public health of our nation.  PrEP is not just for gay men, but for anyone who may be at risk of HIV.

read more

Patient groups file suit to end policy that prohibits copay assistance from counting toward patients’ out-of-pocket spending

Aug 30, 2022

The HIV+Hepatitis Policy Insite, the Diabetes Leadership Council, and the Diabetes Patient Advocacy Coalition filed suit in the U.S. District Court for the District of Columbia challenging a federal rule that allows health insurers and pharmacy benefits managers to avoid counting drug manufacturer copay assistance toward patients’ out-of-pocket cost obligations. Due to increased deductibles and cost-sharing requirements, patients rely on copay assistance to help them afford their #Rx.

read more

CDC data shows only one-third of people diagnosed with hepatitis C access treatment

Aug 9, 2022

Today, the Centers for Disease Control and Prevention (CDC) released disturbing data that shows that only one-third of people diagnosed with hepatitis C who have healthcare coverage are being treated with curative medications within one year of diagnosis. “Despite having health coverage and cost-effective drugs that can cure hepatitis C in as little as 8-12 weeks, our healthcare system is failing to provide the treatment people with hepatitis C need and is required to end this potentially deadly infectious disease,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute.

read more

Senate Appropriations leadership proposes significant increases for domestic HIV programs

Jul 28, 2022

The leadership of the United States Senate Appropriations Committee is proposing to significantly increase funding to continue to ramp up efforts to end HIV in the United States.  The Senate bills include increased funding for the Ending the HIV Epidemic in the U.S. initiative by at least $240 million for domestic HIV testing, prevention, treatment, and research programs. While it is not as much as proposed in President Biden’s budget, in some instances it is more than what was proposed by the House.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing Gay men healthcare Hepatitis Hepatitis C hepatits HIV HIV Prevention hous housing Insurers Medicaid Medicare Part D NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest